Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PPID | Q08752 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25332093 | 0.98 | NPSR1 (0.34) | NPSR1TSHRLTA4HL3MBTL1GLA | |
| SCHEMBL12713106 | 0.88 | SMN1; SMN2 (0.40) | TSHRL3MBTL1ALDH1A1TP53GAA | |
| SCHEMBL7916456 | 0.85 | LTA4H (0.44) | LTA4HL3MBTL1ALDH1A1TP53 | |
| SCHEMBL752002 | 0.83 | KMT2A (0.41) | TSHRLTA4HL3MBTL1MEN1KMT2A | |
| SCHEMBL16260343 | 0.82 | POLB (0.36) | TSHRMEN1KMT2AALDH1A1POLB | |
| SCHEMBL28935869 | 0.82 | ELANE (0.49) | L3MBTL1MEN1KMT2AALDH1A1GAA | |
| SCHEMBL12712829 | 0.80 | ACHE (0.35) | TSHRMEN1KMT2AALDH1A1ACHE | |
| SCHEMBL28153274 | 0.80 | NPSR1 (0.34) | NPSR1TSHRLTA4HL3MBTL1GLA | |
| SCHEMBL1726499 | 0.79 | LTA4H (0.44) | TSHRLTA4HL3MBTL1MEN1KMT2A | |
| SCHEMBL12095490 | 0.78 | TAAR1 (0.40) | TSHRL3MBTL1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478624-B | Telomer of diethyl aluminum phosphinate and preparation method thereof | 兰州瑞朴科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-4388054-A1 | SINGLE-LAYER ADHESIVE FILM AND RELATED ARTICLE | 3M Innovative Properties Company (US) | 2024-06-26 | — | — | EP | claimed |
| CN-117836384-A | Single layer adhesive film and related articles | 3M创新有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-116715698-A | Preparation method of 6-phosphoryl 1,2, 4-triazine-3, 5 (2H, 4H) -diketone derivative | 河北工业大学 | 2023-09-08 | — | — | CN | claimed |
| CN-113583042-B | Preparation method of phosphoryl fluoride compound | 烟台大学 | 2023-08-29 | — | — | CN | claimed |
| WO-2023021463-A1 | SINGLE-LAYER ADHESIVE FILM AND RELATED ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-02-23 | — | — | WO | claimed |
| CN-114478624-A | Telomer of aluminum diethylphosphinate and preparation method thereof | 兰州瑞朴科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114181250-A | Alkenyl phosphine compound and preparation method thereof | 中国石油化工股份有限公司 | 2022-03-15 | — | — | CN | claimed |
| EP-3515454-B1 | CRYSTALLINE POLYMORPHIC FORM OF 3-HYDROXY-4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-PHENYL-2-OXO-2LAMBDA5-[1,2]OXAPHOSPHINANE | PHOSTIN (FR) | 2020-11-11 | — | — | EP | claimed |
| US-10597414-B2 | Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2λ5-[1,2]oxaphosphinane | PHOST'IN (FR) | 2020-03-24 | — | — | US | claimed |
| CN-104662687-B | Salts of phosphorus oxide for use as n-type dopants in organic electronic devices | 西门子公司 | 2019-06-14 | — | — | CN | claimed |
| CN-107922796-A | Self-adhesion multi-layer product and preparation method thereof | 蓝星有机硅法国两合公司 | 2018-04-17 | — | — | CN | claimed |
| WO-2018054925-A1 | CRYSTALLINE POLYMORPHIC FORM OF 3-HYDROXY-4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-PHENYL-2-OXO-2LAMBDA5-[1,2]OXAPHOSPHINANE | PHOST'IN (FR) | 2018-03-29 | — | — | WO | claimed |
| EP-3295944-A1 | CRYSTALLINE POLYMORPHIC FORM OF 3-HYDROXY-4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-PHENYL-2-OXO-2LAMBDA5-[1,2]OXAPHOSPHINANE | PHOST'IN (FR) | 2018-03-21 | — | — | EP | claimed |
| CN-104603212-B | The curable metal finishing compositions of UV | 阿塔卡北美公司 | 2017-07-07 | — | — | CN | claimed |
| CN-102933083-B | The derivative of (1-anocy clopropyl) phenyl phosphinic acid or its ester and/or its salt improve the purposes of plants against abiotic stress tolerance | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-08-12 | — | — | CN | claimed |
| CN-104662687-A | Salts of phosphorus oxide for use as n-type dopants in organic electronic devices | SIEMENS AG | 2015-05-27 | — | — | CN | claimed |
| US-8633127-B2 | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-01-21 | — | — | US | claimed |
| EP-0826690-B1 | Process for the preparation of 2-cyanoethyl-phosphinic acid esters | TICONA GMBH (DE) | 2001-11-14 | — | — | EP | claimed |
| US-4044053-A | Preparation of polyalkylene polyamines | TEXACO DEVELOPMENT CORPORATION (US) | 1977-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10597414-B2 | Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2λ5-[1,2]oxaphosphinane | IPO5, SF3B5, CYP3A5 | NPSR1 3897/4885TSHR 4522/4885LTA4H 1392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.